Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

11 Feb 2010 07:00

RNS Number : 9787G
Halma PLC
11 February 2010
 



Halma p.l.c.

 

Interim Management Statement

 

11 February 2010

 

 

Halma, the leading safety, health and sensor technology group today makes an Interim Management Statement prior to its financial year end on 3 April 2010. This Interim Management Statement covers the period from 4 October 2009 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles) for the full year to be higher than the top of the range of market expectations. The Board believes the current range of market expectations is £78.9million to £82.1million (2008/09 profit before amortisation of acquired intangibles: £79.1million).

 

During the past four-month period, average weekly revenue was 3% higher than we reported for the first half-year ending 3 October 2009. Order intake was ahead of revenue, continuing the positive trend of the first half. The impact of currency exchange rate movements has been broadly neutral relative to the first half.

 

In recent months, profitability has improved in all our three sectors, each benefiting from the actions taken earlier in 2009 to reduce fixed and variable costs.

 

Health and Analysis continues to perform strongly and is expected to report growth in both revenue and profit for the full year. Demand levels in Infrastructure Sensors have continued to be resilient and this, combined with a lower cost base, should enable it to achieve profit growth for the full year. In Industrial Safety, trading has improved gradually although full year revenue and profit are still expected to be below last year's record levels.

 

On 22 January 2010, we announced the acquisition of SphereOptics, LLC for an initial cash consideration of $2.5m (£1.5m) with a deferred purchase consideration of up to $3.5m (£2.1m) based on the growth in profit before tax for the period ending March 2012. SphereOptics manufactures and distributes precision products for use in high technology light measurement applications. Its integration within our Health and Analysis business is proceeding to plan.

 

There have been no material events or transactions impacting the Group's financial position which remains robust and cash generation continues to be strong. We remain well placed to acquire businesses which meet our demanding requirements.

 

The results for the financial year ending 3 April 2010 are expected to be released on 22 June 2010.

 

 

For further information, please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Tel: +44 (0)1494 721111

 

Hogarth Partnership Limited

Rachel Hirst/Andrew Jaques

 

Tel: +44 (0)20 7357 9477

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMZVGRGGZM
Date   Source Headline
15th Oct 20211:06 pmRNSDirector/PDMR Shareholding
4th Oct 20212:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20211:01 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSTrading update
9th Sep 202110:22 amRNSDirector Declaration
9th Aug 20217:00 amRNSM&A Update
26th Jul 202111:01 amRNSDirector/PDMR Shareholding
22nd Jul 20213:00 pmRNSResult of AGM
5th Jul 20214:05 pmRNSDirector/PDMR Shareholding
30th Jun 20211:50 pmRNSDirector/PDMR Shareholding
23rd Jun 20214:47 pmRNSAnnual Financial Report
10th Jun 20217:01 amRNSUnaudited restated segmental information
10th Jun 20217:00 amRNSFull Year Results 2021
27th Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSAppointment of independent non-executive Director
24th Mar 20217:00 amRNSTrading update
23rd Feb 20217:54 amRNSDirector Declaration
10th Feb 20214:52 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSDirectorate Change
21st Dec 20202:00 pmRNSAcquisition
18th Dec 20207:00 amRNSDisposal
4th Dec 20207:04 amRNSDirector Declaration
2nd Dec 20204:08 pmRNSDirector/PDMR Shareholding
25th Nov 20203:20 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSHALF YEAR RESULTS 2020/21
5th Oct 20201:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20207:05 amRNSDirector Declaration
23rd Sep 20207:00 amRNSChair retirement
23rd Sep 20207:00 amRNSTrading update
4th Sep 20204:57 pmRNSResult of AGM
31st Jul 20204:06 pmRNSDirector/PDMR Shareholding
24th Jul 20205:02 pmRNSAnnual Financial Report
17th Jul 20209:32 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSFinal Results
15th May 20201:29 pmRNSElectronic Communications with Shareholders
27th Apr 202012:46 pmRNSDisclosure of Rights Attached to Equity Shares
21st Apr 20207:00 amRNSCOVID-19 Update
2nd Apr 20207:05 amRNSExecutive Board changes
19th Mar 20207:00 amRNSTrading Statement
5th Mar 20209:00 amRNSInvestor Event
24th Feb 202011:31 amRNSHolding(s) in Company
21st Feb 20207:00 amRNSAcquisition
5th Feb 20207:00 amRNSAcquisition
27th Jan 20207:00 amRNSAcquisition
22nd Jan 202012:58 pmRNSChange of Remuneration Committee Chair
29th Nov 20191:27 pmRNSDirector/PDMR Shareholding
25th Nov 20195:10 pmRNSDirector/PDMR Shareholding
19th Nov 201911:45 amRNSDividend Declaration
19th Nov 20197:00 amRNSHalf-year Report
2nd Oct 20195:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.